InvestorsHub Logo
Followers 4
Posts 223
Boards Moderated 0
Alias Born 08/16/2019

Re: powerbattles post# 155

Friday, 02/28/2020 2:47:08 PM

Friday, February 28, 2020 2:47:08 PM

Post# of 3489
Privately held Sharecare, Remark Holdings (MARK) owns about 4.5% of, announced Quest Diagnostics (DGX) as its preferred laboratory partner; Quest also making a strategic investment in the company, 14B investment. This could mean an IPO going forward. Based on current analysis, estimation value of Remark's stake is worth about $150M-$175M, implying about $3.65-$4.31/share, multiples of (MARK)’s current $32M marketcap value. A liquidity event in Sharecare would help to much better capitalize (MARK)'s AI business, and would rid any uncertainty for investors to start heavily investing in (MARK). Causing a huge move up in (MARK)’s price per share. Just valuation alone should cause a correction to a much higher share price, let alone current contracts, upcoming news, contracts and business moves.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MARK News